FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Balversa (erdafitinib) - April 12, 2019
- Evenity (romosozumab-aqqg) - April 09, 2019
- Dovato (dolutegravir and lamivudine) - April 08, 2019
- Asceniv (immune globulin intravenous, human – slra) - April 01, 2019
- Avaclyr (acyclovir) - March 29, 2019
- Duaklir Pressair (aclidinium bromide and formoterol fumarate) - March 29, 2019
- Mavenclad (cladribine) - March 29, 2019
- Jatenzo (testosterone undecanoate) - March 27, 2019
- Mayzent (siponimod) - March 26, 2019
- Sunosi (solriamfetol) - March 20, 2019
- Zulresso (brexanolone) - March 19, 2019
- Rocklatan (netarsudil and latanoprost) - March 12, 2019
- Trazimera (trastuzumab-qyyp) - March 11, 2019
- Spravato (esketamine) - March 05, 2019
- Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) - February 28, 2019
- Adhansia XR (methylphenidate hydrochloride) - February 27, 2019
- Esperoct (turoctocog alfa pegol) - February 19, 2019
- Egaten (triclabendazole) - February 13, 2019
- Cablivi (caplacizumab-yhdp) - February 06, 2019
- Jeuveau (prabotulinumtoxinA-xvfs) - February 01, 2019
